Efficacy of regorafenib combined with PD-1 inhibitors in elderly patients with advanced metastatic colorectal cancer

OBJECTIVE: This is the first clinical study that wants to investigate the treatment patterns, clinical outcomes, and prognostic factors of regorafenib plus PD-1 inhibitors therapy in Chinese elderly patients with advanced colorectal cancer. METHODS: A cohort of metastatic colorectal cancer patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Beibei, Zhao, Huichen, Huang, Jinxi, Lv, Huifang, Xu, Weifeng, Nie, Caiyun, Wang, Jianzheng, Zhao, Jing, He, Yunduan, Wang, Saiqi, Chen, Xiaobing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9769053/
https://www.ncbi.nlm.nih.gov/pubmed/36539696
http://dx.doi.org/10.1186/s12877-022-03637-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9769053/
https://www.ncbi.nlm.nih.gov/pubmed/36539696
http://dx.doi.org/10.1186/s12877-022-03637-9

Ejemplares similares